Fat Loss Activation Complex

Fucus Vesiculosus, Kali Carbonicum, Agave Americana, Capsicum Annuum, Phytolacca Decandra, Aurum Metallicum, Calcarea Carbonica, Ferrum Metallicum, Graphites


True Weight Loss Solutions
Human Otc Drug
NDC 69780-0006
Fat Loss Activation Complex also known as Fucus Vesiculosus, Kali Carbonicum, Agave Americana, Capsicum Annuum, Phytolacca Decandra, Aurum Metallicum, Calcarea Carbonica, Ferrum Metallicum, Graphites is a human otc drug labeled by 'True Weight Loss Solutions'. National Drug Code (NDC) number for Fat Loss Activation Complex is 69780-0006. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Fat Loss Activation Complex drug includes Agave Americana Leaf - 4 [hp_X]/mL Capsicum - 4 [hp_X]/mL Fucus Vesiculosus - 2 [hp_X]/mL Gold - 8 [hp_X]/mL Graphite - 8 [hp_X]/mL Iron - 8 [hp_X]/mL Oyster Shell Calcium Carbonate, Crude - 8 [hp_X]/mL Phytolacca Americana Root - 4 [hp_X]/mL Potassium Carbonate - 2 [hp_X]/mL . The currest status of Fat Loss Activation Complex drug is Active.

Drug Information:

Drug NDC: 69780-0006
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Fat Loss Activation Complex
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Fucus Vesiculosus, Kali Carbonicum, Agave Americana, Capsicum Annuum, Phytolacca Decandra, Aurum Metallicum, Calcarea Carbonica, Ferrum Metallicum, Graphites
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: True Weight Loss Solutions
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:AGAVE AMERICANA LEAF - 4 [hp_X]/mL
CAPSICUM - 4 [hp_X]/mL
FUCUS VESICULOSUS - 2 [hp_X]/mL
GOLD - 8 [hp_X]/mL
GRAPHITE - 8 [hp_X]/mL
IRON - 8 [hp_X]/mL
OYSTER SHELL CALCIUM CARBONATE, CRUDE - 8 [hp_X]/mL
PHYTOLACCA AMERICANA ROOT - 4 [hp_X]/mL
POTASSIUM CARBONATE - 2 [hp_X]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 17 Jul, 2018
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 21 Sep, 2023
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 14 May, 2026
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:True Weight Loss Solutions
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
NUI:N0000185375
N0000185371
N0000175629
N0000184306
M0000728
M0006342
M0016962
M0022575
N0000185508
Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT).
UNII:8511ZMP5QK
00UK7646FG
535G2ABX9M
79Y1949PYO
4QQN74LH4O
E1UOL152H7
2E32821G6I
11E6VI8VEG
BQN1B9B9HA
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class EPC:Non-Standardized Plant Allergenic Extract [EPC]
Non-Standardized Food Allergenic Extract [EPC]
Standardized Chemical Allergen [EPC]
Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`.
Pharmacologic Class PE:Increased Histamine Release [PE]
Cell-mediated Immunity [PE]
Physiologic effect or pharmacodynamic effect—tissue, organ, or organ system level functional activity—of the drug’s established pharmacologic class. Takes the form of the effect, followed by `[PE]` (such as `Increased Diuresis [PE]` or `Decreased Cytokine Activity [PE]`.
Pharmacologic Class CS:Allergens [CS]
Dietary Proteins [CS]
Plant Proteins [CS]
Vegetable Proteins [CS]
Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient].
Pharmacologic Class:Allergens [CS]
Cell-mediated Immunity [PE]
Dietary Proteins [CS]
Increased Histamine Release [PE]
Non-Standardized Food Allergenic Extract [EPC]
Non-Standardized Plant Allergenic Extract [EPC]
Plant Proteins [CS]
Standardized Chemical Allergen [EPC]
Vegetable Proteins [CS]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
69780-0006-130 mL in 1 BOTTLE, DROPPER (69780-0006-1)17 Jul, 201821 Sep, 2023No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Indications: for temporary relief of symptoms related to increased appetite, regulation of fat metabolism, headache, fatigue and detoxification stress.

Product Elements:

Fat loss activation complex fucus vesiculosus, kali carbonicum, agave americana, capsicum annuum, phytolacca decandra, aurum metallicum, calcarea carbonica, ferrum metallicum, graphites fucus vesiculosus fucus vesiculosus potassium carbonate carbonate ion agave americana leaf agave americana leaf capsicum capsicum phytolacca americana root phytolacca americana root gold gold oyster shell calcium carbonate, crude oyster shell calcium carbonate, crude iron iron graphite graphite water alcohol

Indications and Usage:

Indications: for temporary relief of symptoms related to increased appetite, regulation of fat metabolism, headache, fatigue and detoxification stress.

Warnings:

Warnings: keep out of reach of children. in case of overdose, get medical help or contact a poison control center right away. if pregnant or breast-feeding, ask a health professional before use. tamper seal: sealed for your protection. do not use if seal is broken or missing.

Dosage and Administration:

Directions: 10 drops under the tongue, 3 to 6 times a day or as directed by a health professional. consult a physician for use in children under 12 years of age.

Package Label Principal Display Panel:

Package label display: true weight loss solutions fat loss activation complex homeopathic 1 fl oz (30 ml) ndc #: 69780-0006-1 fat loss activation complex

Further Questions:

Questions: dist. by: true weight loss solutions 6102 shallowford road chattanooga, tn 37421


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.